These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19917108)

  • 1. CD10 expression in urothelial carcinoma of the bladder.
    Bahadir B; Behzatoglu K; Bektas S; Bozkurt ER; Ozdamar SO
    Diagn Pathol; 2009 Nov; 4():38. PubMed ID: 19917108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
    Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
    J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 expression in urothelial bladder carcinomas: a pilot study.
    Bircan S; Candir O; Kapucuoglu N; Serel TA; Ciris M; Karahan N
    Urol Int; 2006; 77(2):107-13. PubMed ID: 16888412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10 Is Again Expressed at a Certain Stage during the Neoplastic Process of Bladder Transitional Cell Carcinomas.
    Jang TJ
    Cancer Res Treat; 2012 Dec; 44(4):262-6. PubMed ID: 23341790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients.
    Shukla SK; Chandra S; Chauhan N; Sarpal R
    J Cancer Res Ther; 2021; 17(4):887-892. PubMed ID: 34528537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
    Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.
    Sari A; Calli A; Gorgel SN; Altinboga AA; Kara C; Dincel C; Cakalagaoglu F
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):153-8. PubMed ID: 21623185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 and CA19.9 immunohistochemical expression in transitional cell carcinoma of the urinary bladder.
    Mohammed AS; Ali HH; Qasim BJ; Chaloob MK
    Urol Ann; 2013 Apr; 5(2):81-5. PubMed ID: 23798862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Analysis of p53, CD10 and Ki67 Expression as Prognostic Biomarkers in Urinary Bladder Carcinomas Correlating with Age, Histomorphology, Grade and Stage: An Institutional Study of One and Half Year.
    Mohapatra AS; Mohanty P; Pradhan S; Sabat DK
    J Microsc Ultrastruct; 2023; 11(4):206-213. PubMed ID: 38213648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10 expression in urinary bladder urothelial carcinoma is associated with high-tumor grade and stage.
    Al-Maghrabi J
    Pak J Med Sci; 2023; 39(1):192-197. PubMed ID: 36694735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD10 immunohistochemical staining in urothelial neoplasms.
    Murali R; Delprado W
    Am J Clin Pathol; 2005 Sep; 124(3):371-9. PubMed ID: 16191505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
    Koyuncuer A
    Indian J Pathol Microbiol; 2013; 56(1):10-5. PubMed ID: 23924551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.
    Džombeta T; Krušlin B
    Pathol Oncol Res; 2018 Jul; 24(3):567-574. PubMed ID: 28752222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Large nested variant of urothelial carcinoma of urinary bladder: a clinicopathological analysis of five cases].
    Yin XN; Zhang Q; He XL; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):317-323. PubMed ID: 32268667
    [No Abstract]   [Full Text] [Related]  

  • 17. Fascin determination in urothelial carcinomas of the urinary bladder: a marker of invasiveness.
    Karasavvidou F; Barbanis S; Pappa D; Moutzouris G; Tzortzis V; Melekos MD; Koukoulis G
    Arch Pathol Lab Med; 2008 Dec; 132(12):1912-5. PubMed ID: 19061289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic Evolution of Urothelial Carcinoma Recurrence in Transurethral Resection of the Urinary Bladder:35 Consecutive Cases And Literature Review.
    Koyuncuer A
    Asian Pac J Cancer Prev; 2017 Feb; 18(2):459-463. PubMed ID: 28345830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous and/or glandular differentiation in urothelial carcinoma: prevalence and significance in transurethral resections of the bladder.
    Billis A; Schenka AA; Ramos CC; Carneiro LT; Araújo V
    Int Urol Nephrol; 2001; 33(4):631-3. PubMed ID: 12452615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.